Spectrum Pharmaceuticals/ US84763A1088 /
| 2023-07-31 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.03USD | - | 122,550 Turnover: 124,444.33 |
-Bid Size: - | -Ask Size: - | 211.42 mill.USD | - | - |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .5890 | .3850 | 11.6070 | 3.5770 | .4550 | ||||||
| Intangible Assets | 137.1590 | 111.5940 | - | - | - | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 209.6930 | 140.1980 | 19.4130 | 10.1510 | 7.5960 | ||||||
| Inventories | 5.7150 | 3.5500 | - | - | - | ||||||
| Accounts Receivable | 32.2600 | 29.8730 | .4410 | .0670 | 0.0000 | ||||||
| Cash and Cash Equivalents | 227.3230 | 157.4800 | 64.4180 | 46.0090 | 88.5390 | ||||||
| Current Assets | 277.7460 | 250.6880 | 244.0200 | 186.6470 | 103.9520 | ||||||
| Total Assets | 487.4390 | 390.8860 | 263.4330 | 196.7980 | 111.5480 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 33.6480 | 44.9190 | 54.2840 | 34.3850 | 33.4080 | ||||||
| Long-term debt | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | - | - | ||||||
| Provisions | 1.4000 | 1.5000 | - | - | - | ||||||
| Liabilities | 136.1000 | 107.6240 | 73.0400 | 62.5550 | 63.9950 | ||||||
| Share Capital | .1000 | .1100 | .1130 | .1460 | .1650 | ||||||
| Total Equity | 351.3390 | 283.2620 | 190.3930 | 134.2430 | 47.5530 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 487.4390 | 390.8860 | 263.4330 | 196.7980 | 111.5480 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 128.3670 | 109.3330 | - | - | - | ||||||
| Depreciation (total) | 27.9720 | 28.4090 | 1.6200 | .2610 | .2860 | ||||||
| Operating Result | -96.6600 | -131.1770 | -140.6980 | -169.7340 | -147.7030 | ||||||
| Interest Income | -6.7980 | -.3400 | 4.9960 | 1.3420 | .1630 | ||||||
| Income Before Taxes | -108.0260 | -120.0100 | -144.5940 | -171.3320 | -158.4320 | ||||||
| Income Taxes | 16.7780 | -.0010 | 9.2080 | .0600 | -.0040 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -91.2480 | -120.0110 | -112.6890 | -160.8680 | -158.6280 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -38.8550 | -62.4030 | -134.6310 | -121.6290 | -119.4860 | ||||||
| Cash Flow from Investing Activities | -1.0810 | 1.3730 | 31.9920 | 18.0720 | 108.7110 | ||||||
| Cash Flow from Financing | 108.7210 | -8.4570 | 9.6270 | 85.2300 | 53.3100 | ||||||
| Decrease / Increase in Cash | 69.1010 | -69.8430 | -93.0620 | -18.4090 | 42.5300 | ||||||
| Employees | 215 | 235 | 146 | - | - | ||||||
